Immunosuppressed patients with immune-mediated inflammatory diseases benefit from high post-vaccination antibody levels against COVID-19
The Nor-vaC study underscores the importance of the role of repeated vaccination in patients in patients with immune-mediated inflammatory diseases on immunosuppressive therapies.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
